11 results
2021 ACR/VF Guidelines for Management of Eosinophilic Granulomatosis with Polyangiitis (EGPA)

#EGPA #Eosinophilic #Granulomatosis #Polyangiitis #ACR2021 #Management
2021 ACR/VF Guidelines ... for Management ... of Eosinophilic Granulomatosis ... #rheumatology # ... algorithm #vasculitis
2021 ACR/VF Guidelines for Management of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

#Granulomatosis #Polyangiitis #GPA
2021 ACR/VF Guidelines ... for Management ... of Granulomatosis ... #rheumatology # ... algorithm #vasculitis
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... Nodosa (PAN) • Granulomatosis ... • Eosinophilic Granulomatosis ... Treatment #ACR2021 #Guidelines ... #algorithm #rheumatology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... anticoagulants (DOACs ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Granulomatosis with ... ANCA Vasculitis Management ... Algorithm - ACR ... /VF 2021 Guidelines ... #algorithm #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Eosinophilic Granulomatosis ... ANCA Vasculitis Management ... Algorithm - ACR ... /VF 2021 Guidelines ... #algorithm #rheumatology
Anticoagulation for Atrial Fibrillation - CHA2DS2-VASc

I always tell my students, one of the first thing you
tell my students, one ... have 2 current guidelines ... Both guidelines ... recommend DOAC over ... CHADS2VASC #Score #Management
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Anticoagulation ... #Management #Hematology
Antiphospholipid Syndrome (APS)
APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
and presence of one ... target to 3-4 • DOACs ... APS #diagnosis #management ... #anticoagulation ... #guidelines
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Management during ... Avoid Warfarin and DOAC ... counseling should be done ... suggest prophylactic anticoagulation ... e.g., <50%), ESC guidelines